Clinical Trial Update: G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers [Phase 2]

View source ↗

Summary

Phase 2 trial investigating G-CSF and AMD3100 for mobilizing stem cells in healthy volunteers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• AMD3100 (plerixafor)
• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Healthy | Phase 2 | Status: COMPLETED | Results posted: 2014-05-02